Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001411920-17-000002
Filing Date
2017-08-29
Accepted
2017-08-29 14:31:55
Documents
1
Effectiveness Date
2017-08-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13519
  Complete submission text file 0001411920-17-000002.txt   14682
Mailing Address 654 MADISON AVENUE SUITE 1601 New York NY 10065
Business Address 654 MADISON AVENUE SUITE 1601 New York NY 10065 212-582-1199
IRX Therapeutics, Inc. (Filer) CIK: 0001411920 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-278212 | Film No.: 171057466